Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
GlaxoSmithKline
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:focus |
development of protein and antibody drugs
|
| gptkbp:foundedYear |
1992
|
| gptkbp:founder |
gptkb:William_A._Haseltine
|
| gptkbp:fullName |
gptkb:Human_Genome_Sciences,_Inc.
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
HGSI
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableContributor |
human genome sequencing
|
| gptkbp:notableProduct |
gptkb:Benlysta
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:HGSI
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Human_Genome_Sciences
|
| gptkbp:bfsLayer |
7
|